BIOCORE
Report
- Report Number
- 2249852-2024-00008
- Event Type
- Injury
- Date Received
- May 8, 2024
- Report Date
- June 10, 2024
- Product Code
- MQV
- UDI-DI
- 00813954024769
- PMA / PMN Number
- K182074
- Report Source
- Manufacturer report
- Reporter Occupation
- PHYSICIAN
- Health Professional
- Yes
Narratives
THIS MDR IS FOR SUSPECT DEVICE 2. PLEASE REFER TO MDR NUMBER 2249852-2024-00007 FOR THE PARENT MDR, FOR SUSPECT DEVICE 1. THE PRODUCT MET ACCEPTANCE CRITERIA AND WAS RELEASED WITH CONFORMING ROUTINE TESTING RESULTS.
COMPLAINT WAS RECEIVED THROUGH A CLINICAL DATA COLLECTION. PATIENT DIAGNOSED WITH SPONDYLOLISTHESIS (LUMBAR REGION) AND LUMBAR SPINAL STENOSIS. THE CUSTOMER REPORTED THE BIOCORE PRODUCT WAS USED FOR A POSTEROLATERAL SPINE PROCEDURE ON (B)(6) 2024. TWO ITEM NUMBERS OF BIOCORE PRODUCT WERE PROVIDED BY THE CUSTOMER AND CONFIRMED TO BE USED ON THE PATIENT AT THE SAME TIME FOR THE PROCEDURE. THE BIOCORE PRODUCT WAS IMPLANTED AT VERTEBRAE SITES 3-4 AND 4-5, HOWEVER IT WAS NOT SPECIFIED WHICH PRODUCT WAS UTILIZED AT WHAT VERTEBRAE SITE. THE BIOCORE PRODUCT WAS MIXED WITH BONE MARROW ASPIRATE. ATEC SCREWS AND EXPANDABLE CAGES WERE ALSO USED DURIGN THE PROCEDURE - ONLY THE BIOCORE PRODUCTS ARE MANUFACTURED BY COLLAGEN MATRIX, INC. THE PATIENT'S L3-L4 INTERBODY CAGE HAS BEEN DISPLACED POSTERIORLY, CONFIRMED BY RADIOGRAPHS TAKEN ON (B)(6) 2024. THE INTERBODY CAGE THAT WAS DISPLACED IS NOT MANUFACTURED BY COLLAGEN MATRIX, INC. DURING THE (B)(6) 2024 FOLLOW-UP VISIT THE PATIENT WAS REPORTED TO BE "DOING EXTREMELY WELL POSTOPERATIVELY." NO SIGNIFICANT PAIN REPORTED. THE PATIENT HAD REVISION SURGERY PERFORMED ON (B)(6) 2024. REVISION SURGERY CONSISTED OF THE FOLLOWING SURGERIES: (1) EXPLORATION OF SPINAL FUSION L3-L4, L4-L5; (2) REMOVAL OF L3-L4 POSTERIORLY DISPLACED/MIGRATED INTERBODY CAGE; AND (3) REVISION TRANSFORAMINAL LUMBAR INTERBODY AND POSTERIOR FUSION L3-L4 WITH USE OF NEW INTERBODY CAGE, AUTOGRAFT, ALLOGRAFT. NO COMPLICATIONS FROM REVISION SURGERY REPORTED. THE PATIENT WAS DISCHARGED ON (B)(6) 2024. NO FURTHER INFORMATION ON PATIENT STATUS WAS PROVIDED.
COMPLAINT WAS RECEIVED THROUGH A CLINICAL DATA COLLECTION. PATIENT DIAGNOSED WITH SPONDYLOLISTHESIS (LUMBAR REGION) AND LUMBAR SPINAL STENOSIS. THE CUSTOMER REPORTED THE BIOCORE PRODUCT WAS USED FOR A POSTEROLATERAL SPINE PROCEDURE ON (B)(6) 2024. TWO ITEM NUMBERS OF BIOCORE PRODUCT WERE PROVIDED BY CUSTOMER AND CONFIRMED TO BE USED ON THE PATIENT AT THE SAME TIME FOR THE PROCEDURE. THE BIOCORE PRODUCT WAS IMPLANTED AT VERTEBRAE SITES 3-4 AND 4-5, HOWEVER IT WAS NOT SPECIFIED WHICH PRODUCT WAS UTILIZED AT WHAT VERTEBRAE SITE. THE BIOCORE PRODUCT WAS MIXED WITH BONE MARROW ASPIRATE. ATEC SCREWS AND EXPANDABLE CAGES WERE ALSO USED IN CONJUNCTION WITH THE PRODUCT - THESE DEVICES ARE NOT MANUFACTURED BY COLLAGEN MATRIX, INC. THE PATIENT'S L3-L4 INTERBODY CAGE HAS BEEN DISPLACED POSTERIORLY, CONFIRMED BY RADIOGRAPHS TAKEN ON 4/8/2024. THE INTERBODY CAGE THAT WAS DISPLACED IS NOT MANUFACTURED BY COLLAGEN MATRIX, INC. DURING THE 4/8/2024 FOLLOW-UP VISIT PATIENT WAS "DOING EXTREMELY WELL POSTOPERATIVELY." NO SIGNIFICANT PAIN REPORTED. NO COMPLICATIONS REPORTED DURING INITIAL IMPLANTATION. CUSTOMER CONFIRMED PRODUCT HANDLED AND PERFORMED EXCELLENT. CUSTOMER CONFIRMED REVISION SURGERY WILL BE REQUIRED AT A LATER TIME, HOWEVER NO INFORMATION SURROUNDING THE CONFIRMED REVISION SURGERY WAS PROVIDED (NATURE OF REVISION SURGERY, OUTCOME OF REVISION SURGERY NOT PROVIDED). NO FURTHER INFORMATION ON PATIENT STATUS WAS PROVIDED.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 99993 | BIOCORE | MINERAL COLLAGEN COMPOSITE BIOACTIVE MOLDABLE | MQV | 214-0060-ST | FB220501 | 00813954024769 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | NA | Unknown | Required Intervention |